Misplaced Pages

Technetium (Tc) pentetic acid

Clinical data
Trade names	Draximage DTPA
License data	US DailyMed: Technetium tc 99m pentetate
Routes of administration	Intravenous, inhalation
ATC code	V09CA01 (WHO)
Legal status
Legal status	US: ℞-only
Identifiers
CAS Number	65454-61-7
PubChem CID	73415750
ChemSpider	25016281
UNII	VW78417PU1
Chemical and physical data
Formula	C14H18N3NaO10Tc
Molar mass	509 g·mol
3D model (JSmol)	Interactive image
SMILES C(CN(CC(=O))CC(=O))N(CCN(CC(=O))CC(=O))CC(=O)..
InChI InChI=1S/C14H23N3O10.Na.Tc/c18-10(19)5-15(1-3-16(6-11(20)21)7-12(22)23)2-4-17(8-13(24)25)9-14(26)27;;/h1-9H2,(H,18,19)(H,20,21)(H,22,23)(H,24,25)(H,26,27);;/q;+1;+4/p-5 Key:VTPAYRVYYYAMJN-UHFFFAOYSA-I

Technetium (Tc) pentetic acid, sold under the brand name Draximage DTPA among others, is a radiopharmaceutical medication used in nuclear medicine to image the brain, kidneys, or lungs. It is given by intravenous injection or via aerosol spray. It consists of technetium-99m bound to the conjugate base of pentetic acid, with sodium as an additional cation.

Medical uses

Technetium (Tc) pentetic acid is indicated for use in the diagnosis of the brain, kidneys, or lungs.

References

1. ^ "Draximage DTPA- kit for the preparation of technetium tc 99m pentetate injection, powder, lyophilized, for solution". DailyMed. 8 November 2022. Archived from the original on 5 February 2023. Retrieved 4 February 2023.

• Medicine

This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

• Technetium-99m
• Radiopharmaceuticals
• Pharmacology stubs